`
`Page 1 of 2
`
`FDA Home3Drug Databases4Orange Book5
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Patent and Exclusivity Search Results from query on Appl No 203168 Product 001 in the OB_Rx list.
`
`
`
`Patent Data
`
`Appl No
`
`Prod No
`
`Patent No
`
`Patent
`Expiration
`
`Drug
`Substance
`Claim
`
`Drug Product
`Claim
`
`Patent Use
`Code
`
`Delist
`Requested
`
`N203168
`
`001
`
`8129431
`
`Sep 11, 2025
`
`Y
`
`Y
`
`Exclusivity Data
`
`Appl No
`
`Prod No
`
`Exclusivity Code
`
`N203168
`
`001
`
`NP
`
`Exclusivity Expiration
`Apr 5, 2016
`
`
`Additional information:
`Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53
`1.
`(d)(5).
`Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These
`patents may not be flagged with respect to other claims which may apply.
`
`2.
`
`
`View a list of all patent use codes
`View a list of all exclusivity codes
`Return to Electronic Orange Book Home Page6
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through January 01, 2014
`Patent and Generic Drug Product Data Last Updated: January 24, 2014
`
`Links on this page:
`http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`1.
`http://www.addthis.com/bookmark.php
`2.
`http://www.fda.gov/default.htm
`3.
`http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`4.
`../default.cfm
`5.
`../default.cfm
`6.
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`AccessibilityContact FDACareersFDA BasicsFOIANo Fear ActSite MapTransparencyWebsite Policies
`
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Email FDA
`
`For GovernmentFor Press
`Combination ProductsAdvisory CommitteesScience & ResearchRegulatory InformationSafetyEmergency PreparednessInternational
`ProgramsNews & EventsTraining and Continuing EducationInspections/ComplianceState & Local OfficialsConsumersIndustryHealth
`ProfessionalsFDA Archive
`
`Links on this page:
`http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`1.
`http://www.addthis.com/bookmark.php
`2.
`http://www.fda.gov/default.htm
`3.
`http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`4.
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=203168&P...
`
`1/24/2014
`
`Innopharma EX1013, Page 1
`
`
`
`Patent and Exclusivity Search Results
`
`Page 2 of 2
`
`5.
`6.
`
`../default.cfm
`../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=203168&P...
`
`1/24/2014
`
`Innopharma EX1013, Page 2
`
`